BIOMAT Database Logo BIOMAT Database Logo

Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy. 1990

J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Department of Medicine, School of Medicine, University of Maryland, Baltimore 21201.

Volunteers infected with a chloroquine-susceptible line of Plasmodium falciparum were administered standard oral chloroquine therapy at the first detection of parasites in the blood. Parasitemias progressed in the face of therapy for up to 5 days and to levels up to 100-fold greater than those at the initiation of treatment. Thereafter, infections cleared without a requirement for additional chemotherapy. This course of infection and response to treatment has not been previously reported and may have been detected because volunteers were exposed to an unusually large number of sporozoites. The observations are consistent with the hypothesis that prolonged parasitemia resulted from the continued release of merozoites from liver.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Parasitemia in children with Plasmodium falciparum malaria receiving chemoprophylaxis.
April 2003, The Pediatric infectious disease journal,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Chloroquine-resistant Plasmodium falciparum cerebral malaria in a chloroquine-susceptible area.
November 1999, The Journal of infectious diseases,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Therapy of Plasmodium falciparum parasitemia with desferrioxamine.
August 1992, Blood,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.
June 2017, Science translational medicine,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.
December 2016, Malaria journal,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
May 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates.
August 1995, Experimental parasitology,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
Chloroquine resistance in Plasmodium falciparum.
May 1961, The American journal of tropical medicine and hygiene,
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
[Parasitemia in Plasmodium falciparum malarial attacks in children].
November 1992, Presse medicale (Paris, France : 1983),
J R Murphy, and D F Clyde, and D A Herrington, and S Baqar, and J R Davis, and K Palmer, and J Cortese
[Chloroquine sensitivity of Plasmodium falciparum].
July 1985, Orvosi hetilap,
Copied contents to your clipboard!